Abdelfattah Hassan

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Mass Spectrometry

Molecular Docking

Emergency Department

Metastatic Renal Cell Carcinoma

Top Venues

Journal of enzyme inhibition and medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Amal O A Ibrahim, Abdelfattah Hassan, Ahmed M Mosallam, Ahmed Khodairy, Huda R M Rashdan, Aboubakr Haredi Abdelmonsef
New quinazolin-2,4-dione derivatives incorporating acylthiourea, pyrazole and/or oxazole moieties as antibacterial agents via DNA gyrase inhibition. RSC advances 14 (24) (2024)
Amal O A Ibrahim, Abdelfattah Hassan, Ahmed M Mosallam, Ahmed Khodairy, Huda R M Rashdan, Aboubakr Haredi Abdelmonsef
New quinazolin-2,4-dione derivatives incorporating acylthiourea, pyrazole and/or oxazole moieties as antibacterial agents via DNA gyrase inhibition. RSC advances 14 (24) (2024)
Abdelfattah Hassan, Fawzy A F Mubarak, Ihsan A Shehadi, Ahmed M Mosallam, Hussain Temairk, Mohamed Badr, Aboubakr H Abdelmonsef
Design and biological evaluation of 3-substituted quinazoline-2,4(1 H ,3 H )-dione derivatives as dual c-Met/VEGFR-2-TK inhibitors. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Abdelfattah Hassan, Fawzy A F Mubarak, Ihsan A Shehadi, Ahmed M Mosallam, Hussain Temairk, Mohamed Badr, Aboubakr H Abdelmonsef
Design and biological evaluation of 3-substituted quinazoline-2,4(1 H ,3 H )-dione derivatives as dual c-Met/VEGFR-2-TK inhibitors. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Abdelfattah Hassan, Fawzy A F Mubarak, Ihsan A Shehadi, Ahmed M Mosallam, Hussain Temairk, Mohamed Badr, Aboubakr H Abdelmonsef
Design and biological evaluation of 3-substituted quinazoline-2,4(1 H ,3 H )-dione derivatives as dual c-Met/VEGFR-2-TK inhibitors. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)